Zynerba Pharmaceuticals Inc. (ZYNE) slipped -6.8% or -0.81 to $11.1. It is about 4.23 million shares traded, which is 143.25% compare to the average total volume 2.95 million. The market cap of ZYNE is $233.93 million. The year to date change is 213.36%. The 52 week price range is from $2.75 to $13.06. Price of ZYNE have changed 15.30% during last week. It have changed 119.74% over last month, 147.61% over last 3 months, 127.29% over last 6 months and 15.97% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 6.88. It is -38.02% below current price. The 200-day Moving Averages for ZYNE is 6.23. It is -43.87% below current price. The 52-week High is 13.06. It is 17.66% from the current price. The 52-week Low is 2.75. It is -75.23% from current price.
There are some statistics of ZYNE. It is has market cap $233.93 million. The share outstanding is 21.07 million. The average volume is 2.95 million. The percent of top 15 Institution holding is 18.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -68.84%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -59.82%.